Folliculitis Decalvans: A Review of Current Treatment Modalities

Folliculitis decalvans (FD) is a rare inflammatory scalp disease with an unclear etiology, involving factors like Staphylococcus aureus and immune dysfunction. Current treatment primarily includes systemic antibiotics such as rifampicin and clindamycin, often combined with local therapies. Systemic isotretinoin can lead to sustained remission, and biological agents show potential for severe cases. Emerging treatments like botulinum toxin A injections, Platelet-Rich-Plasma (PRP), and surgical procedures require further randomized double-blind trials to confirm their safety and efficacy.